New subset of T cells may enhance cancer immunotherapy

FHS
May 28, 2024
5:59 pm

A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.

Ipsen files another Onivyde lawsuit two weeks after receiving new patent

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial

SAN DIEGO — An investigational triple-hormone receptor agonist yielded major weight loss in people with obesity, a phase II trial showed. By 24 weeks, patients

June 27, 2023

Risky Drinking Behavior Common Among Cancer Survivors, Even During Treatment

Nearly four in 10 cancer survivors who drank alcohol engaged in risky drinking behaviors, a large retrospective study showed. Overall, 38.3% of survivors who reported

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.